Literature DB >> 8622690

Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas.

G M D'Abaco1, R H Whitehead, A W Burgess.   

Abstract

Colon carcinomas appear to arise from the cumulative effect of mutations to several genes (APC, DCC, p53, ras, hMLH1, and hMSH2). By using novel colonic epithelial cell lines derived from the Immorto mouse, named the YAMC (young adult mouse colon) cell line, and an Immorto-Min mouse hybrid, named the IMCE (Immorto-Min colonic epithelial) cell line, carrying the Apc min mutation, we investigated the effect of an activated v-Ha-ras gene on tumor progression. The YAMC and IMCE cell lines are normal colonic epithelial cell lines which are conditionally immortalized by virtue of expression of a temperature-sensitive simian virus 40 (SV40) large T antigen. Under conditions which permit expression of a functional SV40 large T antigen (33 degrees C plus gamma interferon), neither the YAMC nor the IMCE cell line grows in soft agar or is tumorigenic in nude mice. In vitro, when the SV40 large T antigen is inactivated (39 degrees C without gamma interferon), the cells stop proliferating and die. By infecting the YAMC and IMCE cell lines with a replication-defective psi2-v-Ha-ras virus, we derived cell lines which overexpress the v-Ha-ras gene (YAMC-Ras and IMCE-Ras). In contrast to the parental cell lines, under conditions in which the SV40 large T antigen is inactive, both the YAMC-Ras and IMCE-Ras cell lines continue to proliferate. Initally YAMC-Ras cells do not form tumors; however, tumors are visible after 90 days of incubation. IMCE-Ras cells form colonies in soft agar under both permissive and nonpermissive culture conditions. Furthermore, IMCE-Ras cells form tumors in nude mice within 3 weeks. The phenotype of the IMCE-Ras cell line thus clearly demonstrates that a defective Apc allele and an activated ras gene are sufficient to transform normal colonic epithelial cells and render them tumorigenic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622690      PMCID: PMC231069          DOI: 10.1128/MCB.16.3.884

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

2.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

Authors:  S Shirasawa; M Furuse; N Yokoyama; T Sasazuki
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

3.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Authors:  I Nishisho; Y Nakamura; Y Miyoshi; Y Miki; H Ando; A Horii; K Koyama; J Utsunomiya; S Baba; P Hedge
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

4.  Association between wild type and mutant APC gene products.

Authors:  L K Su; K A Johnson; K J Smith; D E Hill; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

5.  The APC gene product in normal and tumor cells.

Authors:  K J Smith; K A Johnson; T M Bryan; D E Hill; S Markowitz; J K Willson; C Paraskeva; G M Petersen; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.

Authors:  P L Lollini; M C Bosco; F Cavallo; C De Giovanni; M Giovarelli; L Landuzzi; P Musiani; A Modesti; G Nicoletti; G Palmieri
Journal:  Int J Cancer       Date:  1993-09-09       Impact factor: 7.396

7.  Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice.

Authors:  R H Whitehead; P E VanEeden; M D Noble; P Ataliotis; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.

Authors:  W F Dietrich; E S Lander; J S Smith; A R Moser; K A Gould; C Luongo; N Borenstein; W Dove
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia.

Authors:  S H Kim; K A Roth; A R Moser; J I Gordon
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  33 in total

1.  Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation.

Authors:  Clare C Davies; Atanu Chakraborty; Filippo Cipriani; Katharina Haigh; Jody J Haigh; Axel Behrens
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

2.  Aryl Hydrocarbon Receptor Activity of Tryptophan Metabolites in Young Adult Mouse Colonocytes.

Authors:  Yating Cheng; Un-Ho Jin; Clint D Allred; Arul Jayaraman; Robert S Chapkin; Stephen Safe
Journal:  Drug Metab Dispos       Date:  2015-04-14       Impact factor: 3.922

3.  Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Authors:  Charles Giardina; Masako Nakanishi; Awaad Khan; Anton Kuratnik; Wanli Xu; Bruce Brenner; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

4.  Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.

Authors:  Marsha L DeSmet; James C Fleet
Journal:  J Steroid Biochem Mol Biol       Date:  2017-01-16       Impact factor: 4.292

Review 5.  Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.

Authors:  Natividad R Fuentes; Michael L Salinas; Eunjoo Kim; Robert S Chapkin
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-03-22       Impact factor: 3.747

6.  Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA.

Authors:  Jeffrey L Franklin; Carl R Rankin; Shawn Levy; Jay R Snoddy; Bing Zhang; Mary Kay Washington; J Michael Thomson; Robert H Whitehead; Robert J Coffey
Journal:  Biochem Biophys Res Commun       Date:  2013-09-14       Impact factor: 3.575

7.  ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Authors:  Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey
Journal:  Carcinogenesis       Date:  2015-04-27       Impact factor: 4.944

8.  Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.

Authors:  Feijun Luo; David G Brooks; Hongtao Ye; Rifat Hamoudi; George Poulogiannis; Charles E Patek; Douglas J Winton; Mark J Arends
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

9.  Got black swimming dots in your cell culture? Identification of Achromobacter as a novel cell culture contaminant.

Authors:  Jennifer Sue Gray; Janette Marie Birmingham; Jenifer Imig Fenton
Journal:  Biologicals       Date:  2009-11-18       Impact factor: 1.856

Review 10.  Growth control mechanisms in normal and transformed intestinal cells.

Authors:  A W Burgess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.